Market Trends of Global Poultry Healthcare Industry
This section covers the major market trends shaping the Poultry Health Market according to our research experts:
The Vaccines Segment is Expected to Show Better Growth Over the Forecast Period
The vaccine segment is expected to witness significant growth in the poultry healthcare market over the forecast period owing to increased chicken meat production, the rising prevalence of zoonotic diseases, and increased investment in vaccine development by key players to prevent zoonotic diseases. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, with upward improvements for the United Kingdom, Thailand, and Mexico, global chicken meat production for 2023 is estimated to be 102.9 million tons. Similarly, global chicken meat exports for 2023 were estimated to be 14.0 million tons. With the increasing chicken meat production, the need to opt for preventive vaccines to prevent diseases in poultry also increases, which is expected to help the segmental growth over the forecast period.
In addition, the rising company activities in developing vaccines for preventing poultry animals from infections and diseases are also contributing to the market growth. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). Also, in May 2021, Elanco Health Incorporated signed four contracts with EVAH Corp. to acquire and develop technologies in animal health. The four contracts between EVAH and Elanco relate to four products in development (two feed additives and two vaccines) targeting three species: salmon, swine, and poultry.
North America Shows a Significant Market Growth Over the Forecast Period
North America is expected to dominate the global poultry healthcare market over the forecast period, owing to factors such as the rising demand for poultry-derived food products and the rising occurrence of zoonotic diseases in the region. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, chicken meat production in the United States increased from 20,391 in 2021 to 20,845 in 2022, and chicken meat production in Mexico increased from 3,815 in 2021 to 3,900 in 2022. With the increasing poultry production, the number of poultry affected by diseases is also expected to increase. To counter this, the farmers are expected to opt for poultry healthcare, driving market growth over the forecast period.
Additionally, per an article published by the Association of Food and Drug Officials in January 2022, the avian influenza virus has found its way to Canada's Atlantic coast in the Province of Newfoundland and Labrador. Maine has the potential to be the next hotspot for this avian influenza if certain preventative measures are not taken immediately. To stop the spread of the disease and prevent poultry from infections, veterinarians suggest healthcare measures. This is expected to increase the market growth over the forecast period.
Furthermore, the rising product launches in the region are expected to boost the market growth. For instance, in August 2021, Huvepharma Canada Corporation Inc. launched a new vaccine, Clostridium Perfringens Type A, a live vaccine, in Canada. The vaccine can be administered to broiler chickens at the day of age or older for necrotic enteritis (NE) due to Clostridium perfringens type A in broiler chickens. Also, in January 2020, Boehringer Ingelheim's United States Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND, to protect poultry from three diseases, in India. It provides a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease.
